Silence Therapeutics Plc American Depository Share
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $9.02 at 07:20 AM on Oct 19, then ran to $19.61 +117% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is SLN up today? It is at $19.80 (+0.10%), and our scanner flagged it 83 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SLN spikes, and full due diligence on SLN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SLN 83 times in the last 30 days. Create a free account to track $SLN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SLN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SLN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystSilence Therapeutics Enters into Agreement to be Acquired by Merck KGaA, Darmstadt, GermanyReported All-Cash Transaction Values Silence Therapeutics at Approximately $1.3 BillionReported Price of$20.00 Per ADS in CashReported Represents 130% Premium to Silence’s Closing ADS Price on October 16, 2026, from an SEC filing. Read it →Latest filingDEFA14AAdditional proxy materialOct 19, 2026 · 16 days agoAcross every filing on file, supply equal to 105.6% of the tradeable float is in play - 105.6% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
38,888,889 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · Priced at $13.5/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on SLN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SLN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SLN last traded at $19.80, up 0.10% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Silence Therapeutics Plc American Depository Share (SLN) is next expected to report earnings on Thursday, November 5, 2026, which is tomorrow. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SLN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SLN 83 times in the last 30 days.
SLN (Silence Therapeutics Plc American Depository Share) trades on XNAS, with a market cap of about $1.19B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SLN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SLN discussion
Sign in to ask a question or join the discussion.